BioregulatorResearch
Pancragen
Also known as: Lys-Glu-Asp-Trp · KEDW
A tetrapeptide bioregulator for pancreatic function, designed to salvage beta-cells and restore insulin regulation.
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
Half-Life
~30 minutes
Typical Dose
10 mg daily (oral, cycled)
Administration
Oral capsule
Mechanism of Action
Epigenetic modulation of pancreatic gene expression, protecting beta-cells from hyperglycemic stress and enhancing metabolic regulation.
Key Research Areas
bioregulatorpancreasinsulinmetabolic
Frequently Asked Questions
What is Pancragen?▾
A tetrapeptide bioregulator for pancreatic function, designed to salvage beta-cells and restore insulin regulation.
How does Pancragen work?▾
Epigenetic modulation of pancreatic gene expression, protecting beta-cells from hyperglycemic stress and enhancing metabolic regulation.
What is the recommended dosage for Pancragen?▾
The typical research dosage is 10 mg daily (oral, cycled), administered via Oral capsule. Dosage protocols vary by study and should be determined by a qualified healthcare professional.
What is the half-life of Pancragen?▾
The half-life of Pancragen is approximately ~30 minutes. This affects dosing frequency and timing in research protocols.
Is Pancragen FDA approved?▾
Pancragen is currently classified as "Research" and is not FDA approved for general use. It is available for research purposes or through compounding pharmacies depending on your jurisdiction.
Research Disclaimer
The information provided about Pancragen is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.